These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 73419)

  • 21. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
    Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
    Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
    Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)].
    Gatzemeier U
    Prax Klin Pneumol; 1980 Feb; 34(2):102-7. PubMed ID: 7378158
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
    Eagan RT; Maurer LH; Forcier RJ; Tulloh M
    Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 27. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of advanced bronchogenic carcinoma with adriamycin, 5-fluorouracil and methotrexate.
    Anderson G; Thomas G; Stewart-Jones J
    Br J Dis Chest; 1977 Jul; 71(3):179-82. PubMed ID: 302119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined treatment of bronchogenic carcinoma with radiotherapy and cytotoxic drugs--a pilot study using prednimustine and chloroethylcyclohexylnitrosurea (CCNU).
    Bringel C; Jakobsson PA; Könyves I; Nordenskjöld B; Strander H; Wiman LG
    Scand J Respir Dis Suppl; 1978; 102():223-5. PubMed ID: 278211
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination chemotherapy and radiation therapy of undifferentiated small cell bronchogenic carcinoma.
    Lyman GH; Hartmann RC; Saba HI; Preston D; Shukovsky L; Jensen R; Knight M
    South Med J; 1978 May; 71(5):519-24, 529. PubMed ID: 644360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G; Tancini G; Bajetta E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 36. A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinoma.
    Cavalli F; Hasler E; Ryssel HJ; Sonntag RW; Brunner KW
    Tumori; 1977; 63(2):169-73. PubMed ID: 898287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB".
    Bodey GP; Lagakos SW; Gutierrez AC; Wilson HE; Selawry OS
    Cancer; 1977 Mar; 39(3):1026-31. PubMed ID: 71943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH; Muggia FM; Andrews R; Selawry OS
    Cancer; 1972 Aug; 30(2):315-24. PubMed ID: 4559404
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Frankmann C; Murphy WK; Benjamin RS; Barkley HT; McMurtrey MJ; Jeffries DG; Welch SR; Bodey GP
    Cancer; 1987 Jan; 59(2):362-9. PubMed ID: 3026605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved chemotherapy for small-cell undifferentiated lung cancer.
    Einhorn LH; Fee WH; Farber MO; Livingston RB; Gottlieb JA
    JAMA; 1976 Mar; 235(12):1225-9. PubMed ID: 55504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.